Details for Patent: 6,228,874
✉ Email this page to a colleague
Title: | Pharmaceutical composition for angiotensin II-mediated diseases |
Abstract: | This invention relates to a pharmaceutical composition for angiotensin II-mediated diseases, which comprises a compound having angiotensin II antagonistic activity of the formula ##STR1## wherein R.sup.1 is H or an optionally substituted hydrocarbon residue; R.sup.2 is an optionally esterified carboxyl group; R.sup.3 is a group capable of forming an anion or a group convertible thereinto; X is a covalent bond between the 2 phenyl rings or a spacer having a chain length of 1 to 2 atoms as the linear moiety between the adjoining phenylene group and phenyl group; n is 1 or 2; the ring A is a benzene ring having 1 or 2 optional substituents in addition to R.sup.2 ; and Y is a bond, --O--, --S(O)m-- (wherein m is 0, 1 or 2) or --N(R.sup.4)-- (wherein R.sup.4 is H or an optionally substituted alkyl group), or a pharmaceutically acceptable salt thereof in combination with a compound having diuretic activity or a compound having calcium antagonistic activity. |
Inventor(s): | Inada; Yoshiyuki (Kawanishi, JP), Kubo; Keiji (Riverside, CA) |
Assignee: | Takeda Chemical Industries, Ltd. (Osaka, JP) |
Filing Date: | May 04, 2000 |
Application Number: | 09/563,855 |
Claims: | 1. A pharmaceutical composition, which comprises (.+-.)-1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7 -carboxylate or a pharmaceutically acceptable salt thereof in combination with furosemide. 2. A pharmaceutical composition, which comprises 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7 -carboxylic acid or a pharmaceutically acceptable salt thereof in combination with furosemide. 3. A pharmaceutical composition, which comprises 2-ethoxy-1-[[2'-(2,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]meth yl]-1H-benzimidazole-7-carboxylic acid or a pharmaceutically acceptable salt thereof in combination with furosemide. |